A clinical trial evaluating an investigational medication for the treatment of asthma in kids (ages 12 to 17).
Does your child have Asthma?
They may be eligible to participate in our kids asthma study.
This study for kids asthma is evaluating an investigational medication to assess its safety and benefits in treating inflammation in the lungs related to asthma. Asthma is a chronic disease involving the airways (bronchial tubes) in the lungs. These airways allow air to come in and out of the lungs. If you have asthma your airways are always inflamed. They become even more swollen and the muscles around the airways can tighten when something triggers your symptoms. This makes it difficult for air to move in and out of the lungs, causing symptoms such as coughing, wheezing, shortness of breath and/or chest tightness.
Asthma affects people of all ages, but it most often starts during childhood. In the United States, more than 25 million people are known to have asthma. About 7 million of these people are children.
Qualified participants must meet the following requirements:
- Be 12 to 17 years of age
- Have been diagnosed with asthma for at least past 6 months
- Taking a medication for treating asthma for at least 1 month (i.e. Singulair, Flovent)
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel